Product Information
EXFORGE 5-160 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $10.6508 per EA under NDC 00078048815. Its NADAC has been published 413 times since Nov 28, 2013.
FDA first approved this application on Jun 20, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 160 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078048815
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/7/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
New Drug (NDA)
FDA Application
NDA021990FDA Approved
6/20/2007
TE Code
AB
On Market Since
6/20/2007
Pharmacological Classes
Price Statistics
The NADAC for EXFORGE 5-160 MG TABLET has been published 413 times since Nov 28, 2013, and over the history we have for it it has risen 147.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.6508 per EA |
|---|---|
| All-time high | $10.6508 (Aug 19, 2026) |
| All-time low | $4.3106 (Nov 28, 2013) |
| 52-week high | $10.6508 |
| 52-week low | $10.3405 |
| Median price | $7.6845 |
| Average price | $7.3977 |
| Largest weekly change | +21.3% (Nov 19, 2025) |
| Weeks tracked | 413 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate and valsartan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EXFORGE 5-160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EXFORGE 5-160 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $10.6508 per EA (NDC 00078048815), effective Aug 19, 2026.
How has the price of EXFORGE 5-160 MG TABLET changed over time?
Over the history we have for it, the NADAC for EXFORGE 5-160 MG TABLET has risen 147.1%. It has been tracked across 413 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EXFORGE 5-160 MG TABLET?
Since Nov 28, 2013, the NADAC for EXFORGE 5-160 MG TABLET has ranged from a low of $4.3106 (Nov 28, 2013) to a high of $10.6508 (Aug 19, 2026), with a median of $7.6845 per EA.
Are there cheaper alternatives to EXFORGE 5-160 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of EXFORGE 5-160 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EXFORGE 5-160 MG TABLET?
EXFORGE 5-160 MG TABLET (NDC 00078048815) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.